Paclitaxel is chemotherapy
drug classified with the taxane group and used in the
treatment of advanced prostate cancer and recurrent
prostate cancer. Paclitaxel works by stiffening the
microtubules that make up the inner „skeleton‰ of a
cell. Once the microtubules are locked into place, the
cells, which require malleability to divide successfully,
crumble and die during cell division.